Eric Niesor

Eric’s contributions to science include over 100 publications and communications, 73 granted patents. His experience in biopharmaceuticals includes leadership roles as Vice-Director, Distinguished Scientist; Preclinical Science Leader; Head Dyslipidemia Disease Area with focus on HDL at Roche Basel. Prior to this, Eric was Director and Co-founder of Symphar SA (acquired by ILEX Oncology and Genzyme). Eric holds a Ph. D. from the University of Geneva. Thesis directors: Prof. A.E. Renold and Prof. R. Weil: « Transformation of rat pancreatic β-cells by simian virus SV-40 » antitheses

• Pre-clinical science
• Cardiology
• Lipid metabolism
• HDL

• PhD, University of Geneva (Thesis: Transformation of rat pancreatic β-cells by simian virus SV-40)

• French & English